Jarasvaraparn C, Imran H, Siddiqui A, Wilson F, Gremse DA. Association of autoimmune hepatitis type 1 in a child with Evans syndrome. World J Hepatol 2017; 9(23): 1008-1012 [PMID: 28878866 DOI: 10.4254/wjh.v9.i23.1008]
Corresponding Author of This Article
David A Gremse, MD, FAAP, FACG, Department of Pediatrics, University of South Alabama, 1601 Center St, Mobile, AL 36604, United States. dgremse@health.southalabama.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Jarasvaraparn C, Imran H, Siddiqui A, Wilson F, Gremse DA. Association of autoimmune hepatitis type 1 in a child with Evans syndrome. World J Hepatol 2017; 9(23): 1008-1012 [PMID: 28878866 DOI: 10.4254/wjh.v9.i23.1008]
World J Hepatol. Aug 18, 2017; 9(23): 1008-1012 Published online Aug 18, 2017. doi: 10.4254/wjh.v9.i23.1008
Association of autoimmune hepatitis type 1 in a child with Evans syndrome
Chaowapong Jarasvaraparn, Hamayun Imran, Abdul Siddiqui, Felicia Wilson, David A Gremse
Chaowapong Jarasvaraparn, Hamayun Imran, Abdul Siddiqui, Felicia Wilson, Department of Pediatrics, University of South Alabama, Mobile, AL 36604, United States
David A Gremse, Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of South Alabama, Mobile, AL 36604, United States
Author contributions: All authors contributed to the acquisition of data, writing, and revision of this manuscript.
Institutional review board statement: This case report was exempt from the Institutional Review Board standards at University of South Alabama.
Informed consent statement: Our patient’s legal guardian provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors have no conflicts of interest to disclose.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: David A Gremse, MD, FAAP, FACG, Department of Pediatrics, University of South Alabama, 1601 Center St, Mobile, AL 36604, United States. dgremse@health.southalabama.edu
Telephone: +1-251-4343919
Received: February 10, 2017 Peer-review started: February 15, 2017 First decision: April 17, 2017 Revised: June 27, 2017 Accepted: July 7, 2017 Article in press: July 10, 2017 Published online: August 18, 2017 Processing time: 188 Days and 13.6 Hours
Abstract
Autoimmune hepatitis (AIH) is a progressive liver disease that is often associated with extrahepatic autoimmune disorders. Evans syndrome (ES) is a rare autoimmune disorder, which is characterized by immune thrombocytopenia and autoimmune hemolytic anemia. Association of AIH with ES is rare, especially in children. We report a 3-year-old female with a past medical history of ES who presented with jaundice and significant transaminitis due to AIH type 1. She required multiple treatments with steroids as well as azathioprine, intravenous immunoglobulin and a course of rituximab.
Core tip: We report a 3-year-old female with a past medical history of Evans syndrome (ES) who presented with jaundice and significant transaminitis due to autoimmune hepatitis (AIH) type 1. To our knowledge, this is a rare association of concurrent AIH and ES in a child who responded well to rituximab. The patient also demonstrated short-term response to intravenous immunoglobulin, methylprednisolone, azathioprine and oral prednisone. We conclude that ES may evolve over a period of several months therefore evaluation for associated autoimmune conditions should be considered in these patients.
